The rapid initiation of the antiretroviral therapy (ART) and continuous adherence to it may protect CD4+ T cells from HIV-1 infection and elimination, stabilizing the CD4/CD8 ratio (2). This evidence concerns the gene CD8A and HIV-1 infection.